Atlas Trials

Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor

Clinical trial NCT03521037 · COMPLETED

Trial details

NCT number
NCT03521037
Sponsor
pharmaand GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2018-02-27
Primary completion
2019-09-27
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.